http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 15 Oct 2026 09:14:19 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/Hexcel+Corp.+%28HXL%29+PT+Lowered+to+%24105+at+RBC+Capital/27190944.html RBC Capital analyst Ken Herbert lowered the price target on Hexcel Corp. (NYSE: HXL) to $105.00 (from $115.00) while maintaining a Outperform rating. http://www.streetinsider.com/Analyst+PT+Change/Hexcel+Corp.+%28HXL%29+PT+Lowered+to+%24105+at+RBC+Capital/27190944.html Thu, 15 Oct 2026 09:14:19 -0400 HXL http://www.streetinsider.com/Upgrades/Seaport+Global+Securities+Upgrades+Hexcel+Corp.+%28HXL%29+to+Buy/27173096.html <p>Seaport Global Securities analyst Richard Safran upgraded Hexcel Corp. (NYSE: HXL) from Neutral to Buy with a price target of $104.00.</p><p>The analyst comments: “What's changed is that: 1) we recently had a chance to speak with CFO, Jamie Coogan; 2) we think recent A&D selling is overdone and provides a good entry point; and 3) we think Defense demand contributes to above consensus estimates after 2027. In this note, we discuss: our upgrade rationale, takeaways from our conversation with CFO Coogan, what's holding investors back, and what gets the stock to the next level.</p><p>We think current valuation implies too much http://www.streetinsider.com/Upgrades/Seaport+Global+Securities+Upgrades+Hexcel+Corp.+%28HXL%29+to+Buy/27173096.html Mon, 12 Oct 2026 02:16:19 -0400 HXL http://www.streetinsider.com/Analyst+Comments/Seaport+Global+Securities+Upgrades+Hexcel+Corp.+%28HXL%29+to+Buy/27173096.html <p>Seaport Global Securities analyst Richard Safran upgraded Hexcel Corp. (NYSE: HXL) from Neutral to Buy with a price target of $104.00.</p><p>The analyst comments: “What's changed is that: 1) we recently had a chance to speak with CFO, Jamie Coogan; 2) we think recent A&D selling is overdone and provides a good entry point; and 3) we think Defense demand contributes to above consensus estimates after 2027. In this note, we discuss: our upgrade rationale, takeaways from our conversation with CFO Coogan, what's holding investors back, and what gets the stock to the next level.</p><p>We think current valuation implies too much http://www.streetinsider.com/Analyst+Comments/Seaport+Global+Securities+Upgrades+Hexcel+Corp.+%28HXL%29+to+Buy/27173096.html Mon, 12 Oct 2026 02:16:19 -0400 HXL http://www.streetinsider.com/Analyst+PT+Change/Hexcel+Corp.+%28HXL%29+PT+Lowered+to+%2490+at+TD+Cowen/27169239.html TD Cowen analyst Gautam Khanna lowered the price target on Hexcel Corp. (NYSE: HXL) to $90.00 (from $115.00) while maintaining a rating. http://www.streetinsider.com/Analyst+PT+Change/Hexcel+Corp.+%28HXL%29+PT+Lowered+to+%2490+at+TD+Cowen/27169239.html Fri, 09 Oct 2026 07:42:18 -0400 HXL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++HEXCEL+CORP+DE++++++++++For%3A+Oct+02++Filed+by%3A+Li+David+H/27150226.html si-local-file:///var/storage/secattach/20261005/27150226.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++HEXCEL+CORP+DE++++++++++For%3A+Oct+02++Filed+by%3A+Li+David+H/27150226.html Mon, 05 Oct 2026 18:00:00 -0400 HXL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++HEXCEL+CORP+DE++++++++++For%3A+Oct+02++Filed+by%3A+Hubbard+Patricia/27150224.html si-local-file:///var/storage/secattach/20261005/27150224.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++HEXCEL+CORP+DE++++++++++For%3A+Oct+02++Filed+by%3A+Hubbard+Patricia/27150224.html Mon, 05 Oct 2026 18:00:00 -0400 HXL http://www.streetinsider.com/Press+Releases/Hexcel+Schedules+Third+Quarter+2026+Earnings+Release+and+Conference+Call/27132062.html <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL) announced today that it will report financial results for its third quarter of 2026 on Wednesday, October 21 after the market close. </p><p> The company will host a webcast and conference call to discuss highlights of its financial results on Thursday, October 22 at 9:30 a.m. ET. The call will be hosted by Chairman, CEO and President Tom Gentile and Chief Financial Officer Jamie Coogan. </p><p> The event will be webcast via the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F512023355&amp;esheet=54610235&amp;newsitemid=20261001266013&amp;lan=en-US&amp;anchor=Investor+Relations+webpage&amp;index=1&amp;md5=005d97be2839287613eabcaa7653d06c" shape="rect">Investor Relations webpage</a> at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.Hexcel.com&amp;esheet=54610235&amp;newsitemid=20261001266013&amp;lan=en-US&amp;anchor=www.Hexcel.com&amp;index=2&amp;md5=c6568e8f3996080e8d0b4346b616dd08" shape="rect">www.Hexcel.com</a>. The event can also be accessed by dialing http://www.streetinsider.com/Press+Releases/Hexcel+Schedules+Third+Quarter+2026+Earnings+Release+and+Conference+Call/27132062.html Thu, 01 Oct 2026 08:30:00 -0400 HXL http://www.streetinsider.com/Business+Wire/Hexcel+Schedules+Third+Quarter+2026+Earnings+Release+and+Conference+Call/27132062.html <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL) announced today that it will report financial results for its third quarter of 2026 on Wednesday, October 21 after the market close. </p><p> The company will host a webcast and conference call to discuss highlights of its financial results on Thursday, October 22 at 9:30 a.m. ET. The call will be hosted by Chairman, CEO and President Tom Gentile and Chief Financial Officer Jamie Coogan. </p><p> The event will be webcast via the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.q4inc.com%2Fattendee%2F512023355&amp;esheet=54610235&amp;newsitemid=20261001266013&amp;lan=en-US&amp;anchor=Investor+Relations+webpage&amp;index=1&amp;md5=005d97be2839287613eabcaa7653d06c" shape="rect">Investor Relations webpage</a> at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.Hexcel.com&amp;esheet=54610235&amp;newsitemid=20261001266013&amp;lan=en-US&amp;anchor=www.Hexcel.com&amp;index=2&amp;md5=c6568e8f3996080e8d0b4346b616dd08" shape="rect">www.Hexcel.com</a>. The event can also be accessed by dialing http://www.streetinsider.com/Business+Wire/Hexcel+Schedules+Third+Quarter+2026+Earnings+Release+and+Conference+Call/27132062.html Thu, 01 Oct 2026 08:30:00 -0400 HXL http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html <p>Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.</p><p>The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.</p><p>C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and http://www.streetinsider.com/General+News/Wells+Fargo+names+13+stocks+as+overweight+tactical+ideas/27131109.html Thu, 01 Oct 2026 06:30:22 -0400 AXSM CHRW ED FERG FITB HXL KYMR MSCI MSFT OXY RBLX URI VEEV http://www.streetinsider.com/Analyst+PT+Change/Hexcel+Corp.+%28HXL%29+PT+Lowered+to+%24105+at+Wells+Fargo/27124958.html Wells Fargo analyst David Strauss lowered the price target on Hexcel Corp. (NYSE: HXL) to $105.00 (from $120.00) while maintaining a Overweight rating. http://www.streetinsider.com/Analyst+PT+Change/Hexcel+Corp.+%28HXL%29+PT+Lowered+to+%24105+at+Wells+Fargo/27124958.html Wed, 30 Sep 2026 06:47:46 -0400 HXL http://www.streetinsider.com/Analyst+Comments/RBC+Capital+Reiterates+Outperform+Rating+on+Hexcel+Corp.+%28HXL%29/27093903.html <p>RBC Capital analyst Ken Herbert reiterated an Outperform rating and $115.00 price target on Hexcel Corp. (NYSE: HXL).</p><p>The analyst commented: "We hosted two days of meetings with Hexcel (HXL) management. The focus for investors remains the pricing opportunity with Airbus and new aircraft opportunities. Near-term, we believe HXL will continue to benefit from its WB exposure, with potential catalysts around A350 production rates and margin and revenue upside relative to expectations. We also believe capital allocation can be a potential catalyst into 2027 as HXL hits its 2x leverage target. We believe HXL will continue to benefit from its aero http://www.streetinsider.com/Analyst+Comments/RBC+Capital+Reiterates+Outperform+Rating+on+Hexcel+Corp.+%28HXL%29/27093903.html Wed, 23 Sep 2026 08:48:06 -0400 HXL http://www.streetinsider.com/Press+Releases/Hexcel+to+Showcase+Advanced+Composite+Innovations+for+Aerospace%2C+Defense+and+Space+at+CAMX+2026/27083594.html <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL), a global leader in advanced composites technology, will showcase new materials, qualification milestones and manufacturing innovations at the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.thecamx.org%2F&amp;esheet=54607799&amp;newsitemid=20260921201712&amp;lan=en-US&amp;anchor=Composites+and+Advanced+Materials+Expo+%28CAMX%29+2026&amp;index=1&amp;md5=c603af182ab63f7a3927df1c013c865f" shape="rect">Composites and Advanced Materials Expo (CAMX) 2026</a>, Sept. 22-24 in Atlanta. Visitors to Hexcel's Booth P4 will learn how the company is helping customers accelerate the development and production of next-generation aircraft, strengthen defense and space capabilities, and benefit from the advantages of Hexcel’s vertically integrated composites supply chain. </p><p> "CAMX provides an important opportunity to engage with customers, partners and industry leaders as the composites industry prepares for the http://www.streetinsider.com/Press+Releases/Hexcel+to+Showcase+Advanced+Composite+Innovations+for+Aerospace%2C+Defense+and+Space+at+CAMX+2026/27083594.html Mon, 21 Sep 2026 09:00:00 -0400 HXL http://www.streetinsider.com/Business+Wire/Hexcel+to+Showcase+Advanced+Composite+Innovations+for+Aerospace%2C+Defense+and+Space+at+CAMX+2026/27083594.html <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL), a global leader in advanced composites technology, will showcase new materials, qualification milestones and manufacturing innovations at the <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.thecamx.org%2F&amp;esheet=54607799&amp;newsitemid=20260921201712&amp;lan=en-US&amp;anchor=Composites+and+Advanced+Materials+Expo+%28CAMX%29+2026&amp;index=1&amp;md5=c603af182ab63f7a3927df1c013c865f" shape="rect">Composites and Advanced Materials Expo (CAMX) 2026</a>, Sept. 22-24 in Atlanta. Visitors to Hexcel's Booth P4 will learn how the company is helping customers accelerate the development and production of next-generation aircraft, strengthen defense and space capabilities, and benefit from the advantages of Hexcel’s vertically integrated composites supply chain. </p><p> "CAMX provides an important opportunity to engage with customers, partners and industry leaders as the composites industry prepares for the http://www.streetinsider.com/Business+Wire/Hexcel+to+Showcase+Advanced+Composite+Innovations+for+Aerospace%2C+Defense+and+Space+at+CAMX+2026/27083594.html Mon, 21 Sep 2026 09:00:00 -0400 HXL